Filing Details

Accession Number:
0001384101-18-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-11 20:20:23
Reporting Period:
2018-12-10
Accepted Time:
2018-12-11 20:20:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-10 6,695 $2.36 59,236 No 4 M Direct
Common Stock Acquisiton 2018-12-10 1,305 $2.68 60,541 No 4 M Direct
Common Stock Disposition 2018-12-10 8,000 $12.13 52,541 No 4 S Direct
Common Stock Acquisiton 2018-12-11 24,000 $2.36 76,541 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-12-10 6,695 $0.00 6,695 $2.36
Common Stock Stock Option (right to buy) Disposition 2018-12-10 1,305 $0.00 1,305 $2.68
Common Stock Stock Option (right to buy) Disposition 2018-12-11 24,000 $0.00 24,000 $2.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-09-27 No 4 M Direct
100,000 2022-03-09 No 4 M Direct
7,526 2020-09-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,085 Indirect The Bonnie H. Anderson Living Trust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.
  2. Represents weighted average sales price. Sale prices for the transactions range from $11.76 to $12.50. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. The option is fully vested.